08.10.16
Agilent Technologies Inc. plans to build a pharmaceutical manufacturing facility in Weld County, CO. The expansion will more than double its commercial manufacturing capacity for nucleic acid active pharmaceutical ingredients (APIs), and will create 150 to 200 new positions.
“The products manufactured at this site will be used by our customers to improve the lives of patients suffering from a variety of diseases,” said Skip Thune, general manager of the company’s Nucleic Acids Solutions Division. “At Agilent, we are committed to meeting the ever-increasing needs of our customers for oligonucleotides.”
“The Agilent project is a huge win for the Town of Frederick, Weld County and all of Northern Colorado,” said Mike Freeman, chairman of the Weld County Commissioners. “The project adds diversification to our thriving economic base, plus significant new jobs and tax base. It also showcases what an amazing growth region Northern Colorado is due to the diverse workforce and business-friendly environment.”
“The products manufactured at this site will be used by our customers to improve the lives of patients suffering from a variety of diseases,” said Skip Thune, general manager of the company’s Nucleic Acids Solutions Division. “At Agilent, we are committed to meeting the ever-increasing needs of our customers for oligonucleotides.”
“The Agilent project is a huge win for the Town of Frederick, Weld County and all of Northern Colorado,” said Mike Freeman, chairman of the Weld County Commissioners. “The project adds diversification to our thriving economic base, plus significant new jobs and tax base. It also showcases what an amazing growth region Northern Colorado is due to the diverse workforce and business-friendly environment.”